Columbia Care Opens Fourth Cannabist Dispensary in West Virginia; Establishes Wholesale Leadership Position

Cannabist Morgantown is Fourth of Five Planned Dispensaries in State; Company is Only Wholesale Provider in State

NEW YORK--(BUSINESS WIRE)--Apr. 1, 2022-- (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in theU.S., announced today that its newest dispensary inWest Virginia, located at225 Don Knotts BlvdinMorgantown, is now open. Cannabist Morgantown is the fourthColumbia Caredispensary to open in the state in two months and the Company’s 84th nationwide.

“The Cannabist momentum acrossWest Virginiais remarkable, and would not have been possible without a strong local team and the support of theWest Virginia Office of Cannabis Managementand community leaders,” saidAndrew Bayly, Director of Operations – Midwest,Columbia Care. “We are grateful to be able to share our passion for the plant and offer high quality medical cannabis to patients who so desperately need it.”

Columbia Careis currently one of two operators in the state manufacturing product, and is the only operator selling to third party dispensaries, with its product now available in 75% of the state’s dispensaries. Since opening its first dispensary, the Company has launched 20 products under the Seed & Strain brand. The current menu offers eight different strains, as well as six different vape varieties, which are available in two different sizes. Additional in-house brands Triple Seven and Classix are anticipated to launch in the state next quarter, pending regulatory approval.

As the Company’s dispensaries open across the state, theWest Virginiateam is partnering with registered physicians ofReleaf Specialiststo help new patients apply for medical cards. For those who are unable to attend, the staff is directing them to theWest Virginia Department of Health and Human Resourceswebsite which offers a list of registered telehealth providers. Patients will be able to use Columbia Care’s proprietary cannabis discovery tool, Forage, both in-store and online to help find strains and products to fit their needs.

For more information on the Company’sWest Virginialocations, visit

AboutColumbia Care

Columbia Careis one of the largest and most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 18 U.S. jurisdictions and the EU.Columbia Careoperates 131 facilities including 99 dispensaries and 32 cultivation and manufacturing facilities, including those under development.Columbia Careis one of the original multi-state providers of medical cannabis in theU.S.and now delivers industry-leading products and services to both the medical and adult-use markets. In 2021, the company launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber and Platinum Label CBD. For more information onColumbia Care, please visit

Caution Concerning Forward-Looking Statements

This press release contains certain statements that constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable securities laws and reflect the Company’s current expectations regarding future events. Forward-looking statements or information contained in this release include, but are not limited to, statements or information with respect to the Company’s ability to execute on retail, wholesale, brand and product initiatives inWest Virginia. These forward-looking statements or information, which although considered reasonable by the Company, may prove to be incorrect and are subject to known and unknown risks and uncertainties that may cause actual results, performance or achievements of the Company to be materially different from those expressed or implied by any forward-looking information. These risks, uncertainties and other factors include, among others, favorable operating and economic conditions; obtaining and maintaining all required licenses and permits; favorable production levels and sustainable costs from the Company’s operations; and the level of demand for cannabis products, including the Company’s products sold by third parties. In addition, securityholders should review the risk factors discussed under “Risk Factors” in Columbia Care’s Form 10-K datedMarch 31, 2022, filed withU.S. Securities and Exchange Commissionand with the applicable Canadian securities regulatory authorities on SEDAR at and as otherwise described from time to time in documents filed by the Company with Canadian andU.S.securities regulatory authorities.

Lee Ann Evans
Investor Relations

Lindsay Wilson

Source:Columbia Care Inc.

<< Back to Press Releases